198 related articles for article (PubMed ID: 31731733)
1. Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality.
Zati Zehni A; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731733
[TBL] [Abstract][Full Text] [Related]
2. EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases.
Zati Zehni A; Jeschke U; Hester A; Kolben T; Ditsch N; Jacob SN; Mumm JN; Heidegger HH; Mahner S; Vilsmaier T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580276
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.
Zehni AZ; Batz F; Vattai A; Kaltofen T; Schrader S; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478016
[TBL] [Abstract][Full Text] [Related]
4. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
[TBL] [Abstract][Full Text] [Related]
5. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
6. Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology.
Weissenbacher T; Hirte E; Kuhn C; Janni W; Mayr D; Karsten U; Rack B; Friese K; Jeschke U; Heublein S; Dian D; Ditsch N
BMC Cancer; 2013 Jul; 13():361. PubMed ID: 23890049
[TBL] [Abstract][Full Text] [Related]
7. Is Multifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era After Neoadjuvant Chemotherapy and Breast Conservation Therapy?
Ling DC; Sutera PA; Iarrobino NA; Diego EJ; Soran A; Johnson RR; Bhargava R; Champ CE; Beriwal S
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):869-876. PubMed ID: 30885777
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
[TBL] [Abstract][Full Text] [Related]
10. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.
Ustaalioglu BO; Bilici A; Kefeli U; Şeker M; Oncel M; Gezen C; Gumus M; Demirelli F
Am J Clin Oncol; 2012 Dec; 35(6):580-6. PubMed ID: 21926901
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary report.
Müller K; Sixou S; Kuhn C; Jalaguier S; Mayr D; Ditsch N; Weissenbacher T; Harbeck N; Mahner S; Cavaillès V; Jeschke U
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669416
[TBL] [Abstract][Full Text] [Related]
12. Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.
Al-Azhri J; Zhang Y; Bshara W; Zirpoli G; McCann SE; Khoury T; Morrison CD; Edge SB; Ambrosone CB; Yao S
Clin Cancer Res; 2017 Jan; 23(1):97-103. PubMed ID: 27407090
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer.
Shiino S; Kinoshita T; Yoshida M; Jimbo K; Asaga S; Takayama S; Tsuda H
Clin Breast Cancer; 2016 Aug; 16(4):e133-40. PubMed ID: 27268749
[TBL] [Abstract][Full Text] [Related]
15. Survival outcome of weak estrogen/progesterone receptor expression in HER2 negative breast cancer is similar to triple negative breast cancer.
Liao GS; Dai MS; Hsu HM; Chu CH; Hong ZJ; Fu CY; Chou YC; Huang TC; Yu JC
Eur J Surg Oncol; 2017 Oct; 43(10):1855-1861. PubMed ID: 28756019
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor (VDR) expression is not a prognostic factor in breast cancer.
Friedrich M; Villena-Heinsen C; Tilgen W; Schmidt W; Reichrat J; Axt-Fliedner R
Anticancer Res; 2002; 22(3):1919-24. PubMed ID: 12168894
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial.
Aalders KC; Kuijer A; Straver ME; Slaets L; Litiere S; Viale G; Van't Veer LJ; Glas AM; Delorenzi M; van Dalen T; Tryfonidis K; Piccart MJ; Cardoso F; Rutgers EJ;
Eur J Cancer; 2017 Jul; 79():98-105. PubMed ID: 28477490
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological response to neoadjuvant chemotherapy based on primary tumor reduction is correlated to survival in hormone receptor-positive but not hormone receptor-negative locally advanced breast cancer.
Chen S; Liu Y; Ouyang QW; Huang L; Luo RC; Shao ZM
Ann Surg Oncol; 2015 Jan; 22(1):32-9. PubMed ID: 25012266
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor expression in invasive breast tumors and breast cancer survival.
Huss L; Butt ST; Borgquist S; Elebro K; Sandsveden M; Rosendahl A; Manjer J
Breast Cancer Res; 2019 Jul; 21(1):84. PubMed ID: 31358030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
